TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Portnoy Law Firm Announces Class Action on Behalf of Telix Pharmaceuticals Limited Investors

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Portnoy Law Firm
Portnoy Law Firm Announces Class Action on Behalf of Telix Pharmaceuticals Limited Investors

The Portnoy Law Firm has announced a class action lawsuit on behalf of Telix Pharmaceuticals Limited investors who purchased securities between February 21, 2025 and August 28, 2025. The lawsuit alleges that Telix made false and misleading statements regarding the progress of its prostate cancer therapeutic candidates and overstated the quality of its supply chain and business partners. Investors have until January 9, 2026 to file a lead plaintiff motion.

Insights
TLX   negative

The company is the subject of a class action lawsuit alleging material misstatements about prostate cancer therapeutic progress and supply chain quality, indicating significant corporate governance and disclosure failures that resulted in investor losses.